• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Gemcitabine Medac
    / Tzamal


    Active Ingredient
    Gemcitabine (HCl) 200, 1000, 1500 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Vial

    1 X 200 mg

    partial basket chart 15839 7841

    Vial

    1 X 1000 mg

    partial basket chart 15840 7842

    Vial

    1 X 1500 mg

    partial basket chart 15841 7843

    Dosage

    Method of administration: Gemcitabine is tolerated well during infusion and may be administered ambulant. If extravasation occurs, generally the infusion must be stopped immediately and started again in another blood vessel. The patient should be monitored carefully after the administration.
    See prescribing information for full details.


    Indications

    Non-Small Cell Lung Cancer: Gemcitabine is indicated for the palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer.
    Breast cancer: Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant / neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.
    Pancreatic Cancer: Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer.
    Bladder Cancer: Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage.
    Ovarian cancer: Gemcitabine in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma who have relapsed at least six months after platinumbased therapy.


    Contra-Indications

    Hypersensitivity to the active substance or to any of the excipients. Lactation.

     


    Special Precautions

    See prescribing information for full details.


    Side Effects

    See prescribing information for full details.


    Drug interactions

    See prescribing information for full details.


    Manufacturer
    medac GmbH
    CLOSE